Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advancements and challenges in developing in vivo CAR T cell therapies for cancer treatment
Thuỳ Anh Bùi, Haoqi Mei, Rui Sang, et al.
EBioMedicine (2024) Vol. 106, pp. 105266-105266
Open Access | Times Cited: 15

Showing 15 citing articles:

A new era of cancer immunotherapy: vaccines and miRNAs
Gitika Sareen, Maneesh Mohan, Ashi Mannan, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 5
Open Access | Times Cited: 2
iPSC-derived CD19 CAR NK cells for relapsed or refractory lymphoma
Roman M. Shapiro, Rizwan Romee
The Lancet (2025) Vol. 405, Iss. 10473, pp. 98-99
Closed Access | Times Cited: 1
T Cell Therapies (TIL, CAR T, TCR)
Maximilian Julve
Elsevier eBooks (2025)
Closed Access
Sex hormones, the anticancer immune response, and therapeutic opportunities
Fabio Conforti, Laura Pala, Diletta Di Mitri, et al.
Cancer Cell (2025) Vol. 43, Iss. 3, pp. 343-360
Open Access
Mesenchymal stromal cells in bone marrow niche of patients with multiple myeloma: a double-edged sword
Sina Kamrani, Reza Naseramini, Pouria Khani, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
In Vivo Engineered CAR-T Cell Therapy: Lessons Built from COVID-19 mRNA Vaccines
Sikun Meng, Tomoaki Hara, Yutaka Miura, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3119-3119
Open Access
Progress and challenges in developing allogeneic cell therapies
T. Deuse, Sonja Schrepfer
Cell stem cell (2025) Vol. 32, Iss. 4, pp. 513-528
Open Access
Chimeric autoantibody receptor T cells specifically eliminate Graves’ Disease autoreactive B cells
Abigail Cheever, Hunter G. Lindsay, Chloe C. Kang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Spotlight on cancer immunotherapies

Nature Biotechnology (2025) Vol. 43, Iss. 4, pp. 453-454
Closed Access
Perspectives on the use and availability of Chimeric Antigen Receptor T Cells (CAR-T) and Cell Therapies: A worldwide cross-sectional survey by the Worldwide Network for Blood and Marrow Transplantation (WBMT)
Eng M. Tan, Mahmoud Aljurf, Fazal Hussain, et al.
Current Research in Translational Medicine (2025) Vol. 73, Iss. 2, pp. 103515-103515
Closed Access
Natural killer cell–based immunotherapy for cancer
Shoubao Ma, Jianhua Yu, Michael A. Caligiuri
The Journal of Immunology (2025)
Open Access
State of the art in CAR-based therapy: In vivo CAR production as a revolution in cell-based cancer treatment
Abdolreza Esmaeilzadeh, Kaveh Hadiloo, Sara Yaghoubi, et al.
Cellular Oncology (2025)
Open Access
Neoantigen-based immunotherapy: advancing precision medicine in cancer and glioblastoma treatment through discovery and innovation
Moawiah M. Naffaa, Ola A Al-Ewaidat, Sopiko Gogia, et al.
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access
Advances and challenges in CAR-T cell therapy for head and neck squamous cell carcinoma
Sahand Saeidpour Masouleh, Kamyar Nasiri, Ava Ostovar Ravari, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Addressing graft-versus-host disease in allogeneic cell-based immunotherapy for cancer
Zibai Lyu, Shaoqiang Niu, Ying Fang, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
Recent advances of chimeric antigen receptor T‐cell therapy for acute myeloid leukemia
Yang Liu, Wanting Wang, Chaofan Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Advancing the next generation of cancer treatment with circular RNAs in CAR-T cell therapy
Sanxiong Huang, Juling Xu, Natalia Baran, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 181, pp. 117753-117753
Open Access | Times Cited: 1
Translational PK–PD model for in vivo CAR‐T‐cell therapy delivered using CAR mRNA‐loaded polymeric nanoparticle vector
Se Jin Kim, Ganesh M. Mugundu, Aman P. Singh
Clinical and Translational Science (2024) Vol. 17, Iss. 12
Open Access | Times Cited: 1
Page 1

Scroll to top